Target
Vascular endothelial growth factor receptor 3 [818-948,1003-1077]
Ligand
BDBM176588
Substrate
n/a
Meas. Tech.
Biochemical Assay
pH
7.4±n/a
IC50
3685±n/a nM
Comments
extracted
Citation
 Holmes, IPBergman, YLunniss, GENikac, MChol, NHemley, CFWalker, SRFoitzik, RCGaname, DLessene, R Selective FAK inhibitors US Patent  US9120761 Publication Date 9/1/2015 
Target
Name:
Vascular endothelial growth factor receptor 3 [818-948,1003-1077]
Synonyms:
FLT4 | VEGFR3 | VGFR3_HUMAN | modified VEGFR3 cytoplasmic domain
Type:
n/a
Mol. Mass.:
34324.27
Organism:
Homo sapiens (Human)
Description:
P35916[818-948,1003-1077]
Residue:
306
Sequence:
DPGEVPLEEQCEYLSYDASQWEFPRERLHLGRVLGYGAFGKVVEASAFGIHKGSSCDTVAVKMLKEGATASEHRALMSELKILIHIGNHLNVVNLLGACTKPQGPLMVIVEFCKYGNLSNFLRAKRDAFSPDLWLSPLTMEDLVCYSFQVARGMEFLASRKCIHRDLAARNILLSESDVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLRDGTRMRAPELATPAIRRIMLNCWSGDPKARPAFSELVEILGDLLQGRG
  
Inhibitor
Name:
BDBM176588
Synonyms:
US9120761, 2
Type:
Small organic molecule
Emp. Form.:
C27H30F3N5O2
Mol. Mass.:
513.5546
SMILES:
COc1cc(ccc1Nc1ncc(c(CCc2ccccc2CC(N)=O)n1)C(F)(F)F)C1CCNCC1
Structure:
Search PDB for entries with ligand similarity: